Maravai LifeSciences Holdings, Inc. (MRVI) vs Sarepta Therapeutics, Inc. (SRPT)
- Maravai LifeSciences Holdings, Inc. MRVI 6.79 −3.96%
- Sarepta Therapeutics, Inc. SRPT 17.06 −4.10%
Maravai LifeSciences Holdings, Inc. and Sarepta Therapeutics, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Sarepta Therapeutics, Inc. are of similar size ($1.9B and $1.8B). Maravai LifeSciences Holdings, Inc. grew revenue faster over the last twelve months: −5.03% against −20.4%. Sarepta Therapeutics, Inc. has the higher net margin (−6.93% vs −37.1%) and the higher return on invested capital (−5.64% vs −15.8%). Across the 18 metrics below, Sarepta Therapeutics, Inc. leads on 13 and Maravai LifeSciences Holdings, Inc. on 5.
Valuation
Profitability
| Metric | MRVI | SRPT | Biotechnology median |
|---|---|---|---|
| Gross margin | 34.89% | 59.09% | 65.16% |
| Operating margin | (56.08%) | (7.26%) | 0.00% |
| Net margin | (37.07%) | (6.93%) | 0.00% |
| Free cash flow margin | (17.17%) | 3.80% | 0.00% |
| Return on equity | (18.79%) | (9.48%) | (56.36%) |
| Return on assets | (10.31%) | (3.98%) | (48.04%) |
| Return on invested capital | (15.83%) | (5.64%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack